DigitalHealth InvestorTalk: Strategic Alternatives for Zombicorns
Thu Jan 29 2026
What's next for funded companies with growth issues?
After the euphoria of the Zero Interest Rate Period (ZIRP) when many companies received significant funding at high valuations, reality has set in for many of those companies. Slower than expected growth, missed milestones, and a more selective funding environment are forcing tough choices on the management teams of these companies.
In this show we'll cover:
The changing opportunities and challenges for digital health companiesThe investors' perspectivesThe range of strategic alternatives available to companies
And we'll answer your questions.
Ron Razmi, MD, is the Managing Director of Zoi, a health AI advisory and investment firm, and the author of AI Doctor: The Rise of Artificial Intelligence in Healthcare. A cardiologist by training, he was previously a McKinsey consultant and CEO of health technology company. He currently writes a column for Fast Company and the The AI Doctor Blog on substack, and comments regularly on CNBC, Fox Business, and other media outlets on the health economy.
Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.
Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.
Subscribe to the podcast!
Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ
More
What's next for funded companies with growth issues? After the euphoria of the Zero Interest Rate Period (ZIRP) when many companies received significant funding at high valuations, reality has set in for many of those companies. Slower than expected growth, missed milestones, and a more selective funding environment are forcing tough choices on the management teams of these companies. In this show we'll cover: The changing opportunities and challenges for digital health companiesThe investors' perspectivesThe range of strategic alternatives available to companies And we'll answer your questions. Ron Razmi, MD, is the Managing Director of Zoi, a health AI advisory and investment firm, and the author of AI Doctor: The Rise of Artificial Intelligence in Healthcare. A cardiologist by training, he was previously a McKinsey consultant and CEO of health technology company. He currently writes a column for Fast Company and the The AI Doctor Blog on substack, and comments regularly on CNBC, Fox Business, and other media outlets on the health economy. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com. Subscribe to the podcast! Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ